NO20074505L - Partikkel og preparat inneholdende partikkelen - Google Patents

Partikkel og preparat inneholdende partikkelen

Info

Publication number: NO20074505L
Authority: NO; Norway
Prior art keywords: particle; particles; preparation containing; amino; benzylpiperidin
Prior art date: 2005-03-09

Application number

NO20074505A

Other languages

English (en)

Norwegian (no)

Inventor

Hideo Masuda

Hikaru Sugihara

Akio Nashiura

Kazuyuki Hayashi

Original Assignee

Ono Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-09

Filing date

2007-09-05

Publication date

2007-12-10

2007-09-05 Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co

2007-12-10 Publication of NO20074505L publication Critical patent/NO20074505L/no

Links

239000002245 particle Substances 0.000 title abstract 5
238000002360 preparation method Methods 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 abstract 1
210000004072 lung Anatomy 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
KCVLHOGZZRHCEW-SVBPBHIXSA-N tert-butyl (4r)-4-[[(2r)-1-[(1-benzylpiperidin-4-yl)amino]-3-(cyclohexylmethylsulfanyl)-1-oxopropan-2-yl]carbamoyl]-1,3-thiazolidine-3-carboxylate Chemical compound CC(C)(C)OC(=O)N1CSC[C@H]1C(=O)N[C@H](C(=O)NC1CCN(CC=2C=CC=CC=2)CC1)CSCC1CCCCC1 KCVLHOGZZRHCEW-SVBPBHIXSA-N 0.000 abstract 1
230000007704 transition Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

NO20074505A 2005-03-09 2007-09-05 Partikkel og preparat inneholdende partikkelen NO20074505L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2005066158		2005-03-09
PCT/JP2006/304506 WO2006095788A1 (fr)	2005-03-09	2006-03-08	Particule et preparation la contenant

Publications (1)

Publication Number	Publication Date
NO20074505L true NO20074505L (no)	2007-12-10

Family

ID=36953382

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20074505A NO20074505L (no)	2005-03-09	2007-09-05	Partikkel og preparat inneholdende partikkelen

Country Status (13)

Country	Link
US (1)	US20090022915A1 (fr)
EP (1)	EP1857114A1 (fr)
JP (1)	JPWO2006095788A1 (fr)
KR (1)	KR20070110418A (fr)
CN (1)	CN101171023A (fr)
AU (1)	AU2006221364A1 (fr)
BR (1)	BRPI0608844A2 (fr)
CA (1)	CA2602007A1 (fr)
IL (1)	IL185590A0 (fr)
NO (1)	NO20074505L (fr)
RU (1)	RU2007137121A (fr)
WO (1)	WO2006095788A1 (fr)
ZA (1)	ZA200707436B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN103285015B (zh) *	2007-04-13	2016-04-27	化学基因制药公司	三尖杉碱口服剂型
WO2009047935A1 (fr) *	2007-10-12	2009-04-16	Ono Pharmaceutical Co., Ltd.	Particules fines

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2764274B2 (ja) *	1988-03-28	1998-06-11	株式会社ミドリ十字	医薬組成物
JPH07291854A (ja) *	1994-04-26	1995-11-07	Tanabe Seiyaku Co Ltd	溶解性の改善された医薬品製剤
MA25590A1 (fr) *	1998-09-14	2002-12-31	Inhale Therapeutic Syst	Agent actif de delivraison de poudre seche
PE20011227A1 (es) *	2000-04-17	2002-01-07	Chiesi Farma Spa	Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
AU2001266392A1 (en) *	2000-06-27	2002-01-08	Mi Tech Company Limited	The controlled release preparation of insulin and its method
CA2478327A1 (fr) *	2002-03-20	2003-10-02	Advanced Inhalation Research, Inc.	Preparations d'hormone de croissance humaine (hch) destinees a etre administrees par voie pulmonaire
SI2630954T1 (sl) *	2002-03-20	2017-02-28	Civitas Therapeutics, Inc.	Pulmonalno dovajanje za levodopo
JP2004175795A (ja) *	2002-11-13	2004-06-24	Takeda Chem Ind Ltd	薬物の放出性に優れた医薬組成物
DK1567164T3 (da) *	2002-11-26	2009-05-18	Alexza Pharmaceuticals Inc	Anvendelse af loxapin til fremstilling af et lægemiddel til behandling af smerte
WO2004113332A1 (fr) *	2003-06-19	2004-12-29	Ono Pharmaceutical Co., Ltd.	Preparations nasales

2006
- 2006-03-08 BR BRPI0608844-9A patent/BRPI0608844A2/pt not_active IP Right Cessation
- 2006-03-08 WO PCT/JP2006/304506 patent/WO2006095788A1/fr not_active Ceased
- 2006-03-08 AU AU2006221364A patent/AU2006221364A1/en not_active Abandoned
- 2006-03-08 CA CA002602007A patent/CA2602007A1/fr not_active Abandoned
- 2006-03-08 EP EP06728775A patent/EP1857114A1/fr not_active Withdrawn
- 2006-03-08 US US11/908,091 patent/US20090022915A1/en not_active Abandoned
- 2006-03-08 CN CNA2006800160095A patent/CN101171023A/zh active Pending
- 2006-03-08 KR KR1020077022785A patent/KR20070110418A/ko not_active Withdrawn
- 2006-03-08 JP JP2007507162A patent/JPWO2006095788A1/ja active Pending
- 2006-03-08 RU RU2007137121/15A patent/RU2007137121A/ru unknown
2007
- 2007-08-29 IL IL185590A patent/IL185590A0/en unknown
- 2007-08-30 ZA ZA200707436A patent/ZA200707436B/xx unknown
- 2007-09-05 NO NO20074505A patent/NO20074505L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN101171023A (zh)	2008-04-30
KR20070110418A (ko)	2007-11-16
WO2006095788A1 (fr)	2006-09-14
US20090022915A1 (en)	2009-01-22
ZA200707436B (en)	2009-08-26
CA2602007A1 (fr)	2006-09-14
BRPI0608844A2 (pt)	2010-02-02
EP1857114A1 (fr)	2007-11-21
AU2006221364A1 (en)	2006-09-14
IL185590A0 (en)	2008-01-06
RU2007137121A (ru)	2009-04-20
JPWO2006095788A1 (ja)	2008-08-14

Publication	Publication Date	Title
MX2009005048A (es)	2009-05-25	Nuevo proceso para la preparacion de derivados de 2-imino-tiazolidin-4-ona.
WO2008021927A3 (fr)	2008-05-29	Inhibiteurs du virus de l'hépatite c
WO2008066899A3 (fr)	2009-04-16	Formulations de nanoparticules et procédés de préparation et d'utilisation de celles-ci
MX2011012196A (es)	2013-05-30	Composiciones y metodos para el suministro de farmaco.
EA200801468A1 (ru)	2009-04-28	Препараты ганаксолона и способы их получения и применения
NZ621174A (en)	2015-09-25	Powdered protein compositions and methods of making same
WO2008061243A3 (fr)	2008-10-16	Particules de type viral (vlp) apparentées au virus respiratoire syncytial
WO2004043381A3 (fr)	2005-01-27	Compositions et methodes de prolongement de la survie des plaquettes
WO2006069155A3 (fr)	2006-11-23	Inhibiteurs de methyl-transferases d'arginine de proteines
WO2007041156A3 (fr)	2008-03-06	Formulations d'antibiotiques, doses posologiques, necessaires, et procedes
BRPI0719393B8 (pt)	2021-05-25	composição farmacêutica
WO2006029233A3 (fr)	2006-10-05	Compositions et methodes d'allongement de la survie de plaquettes
WO2009100265A3 (fr)	2009-11-05	Compositions et méthodes pour le traitement de la xérostomie
SG151331A1 (en)	2009-04-30	Crystalline polymorph of a bazedoxifene acetate
NO20083535L (no)	2008-08-14	Alfa-krystallinsk form av argininsaltet til perindopril, en prosess for dets fremstilling og farmasoytiske sammensetninger inneholdende dette
WO2011025982A3 (fr)	2011-09-22	Composés tétracycline
WO2008067436A3 (fr)	2008-07-17	Composés et formulations appropriés pour une désactivation de radicaux
MX2008002484A (es)	2008-04-07	Formulaciones de acetato de bazedoxifeno y proceso de fabricacion de los mismos.
WO2006044790A3 (fr)	2006-06-15	Compositions et procedes d'allongement de la survie de plaquettes
WO2008035380A3 (fr)	2008-05-08	Procédé amélioré de préparation de formotérol de grande pureté et de ses sels pharmaceutiquement acceptables
NO20074505L (no)	2007-12-10	Partikkel og preparat inneholdende partikkelen
UA86055C2 (ru)	2009-03-25	Кристаллическая форма в базедоксифена ацетата
WO2008101247A3 (fr)	2008-11-27	Composes substitues en 6 presentant une affinite avec le recepteur 5-ht6
NZ610862A (en)	2015-07-31	Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
UA86056C2 (ru)	2009-03-25	Твердый дисперсионный состав базедоксифена ацетата, способ его получения (варианты) и применение (варианты)

Legal Events

Date	Code	Title	Description
2009-10-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application